Biomaterial

• US 6,666,214 B2
• Filed: 09/28/2001
• Issued: 12/23/2003
• Est. Priority Date: 08/03/1995
• Status: Expired due to Term

• Current Assignee: pSiMedica Limited (EyePoint Pharmaceuticals, Inc.)
• Original Assignee: pSiMedica Limited (EyePoint Pharmaceuticals, Inc.)
• Inventors: Canham, Leigh T
• Primary Examiner(s): STEIN, STEPHEN J
• Application Number:
  US09/964,361
• Publication Number:
  US 20020034646A1
• Time in Patent Office: 816 Days
• Field of Search: 623/23.75, 623/902, 623/11.11, 424/426, 128/899, 204/403.01, 604/890.1, 604/891.1
• US Class Current: 128/899
• CPC Class Codes: A61F 2310/0061 Coating made of silicon oxide or hydroxides
• CPC Class Codes: A61F 2310/00796 Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
• CPC Class Codes: A61L 27/025 Other specific inorganic materials not covered by A61L27/04 - A61L27/12
• CPC Class Codes: A61L 27/306 Other specific inorganic materials not covered by A61L27/303 - A61L27/32
• CPC Class Codes: A61L 27/32 Phosphorus-containing materials, e.g. apatite
• CPC Class Codes: A61L 27/56 Porous materials, e.g. foams or sponges

Abstract

Biomaterial, for example bioactive silicon, may be fabricated by anodizing a silicon wafer to produce a wafer having a porous silicon region. In vitro experiments have shown that certain types of porous silicon cause the deposition of apatite deposits both on the porous silicon and neighboring areas of bulk silicon when immersed in a simulated body fluid solution. This deposition of apatite provides an indication that porous silicon of appropriate form is bioactive, and therefore also biocompatible. A form of porous silicon is dissolved in the simulated body fluid solution and this is an indication of a resorbable biomaterial characteristic. In addition to porous silicon, certain types of polycrystalline silicon exhibit bioactive characteristics. Bioactive silicon may be used in the fabrication of biosensors for in vitro or in vivo applications. The bioactivity of the bioactive silicon may be controlled by the application of an electrical potential thereto.

Claims

1. A method of implantation comprising the step of implanting an electronic device within a living human or animal body, wherein the device includes bioactive silicon.

2. A method according to claim 1, wherein the bioactive silicon comprises at least partially porous silicon having a porosity greater than 4% and less than 70%.

3. A method according to claim 2, wherein the porous silicon contains macropores for enhancing vascular tissue ingrowth.

4. A method according to claim 2, wherein the porous silicon extends at least partially over an outer surface of the device.

5. A method according to claim 1, wherein the device is a sensor device.

6. A method according to claim 1, wherein the bioactive silicon is polycrystalline silicon.

7. A method of delivering a drug to a living animal or human comprising placing the drug to be delivered on or within a bioactive silicon structure, and thereafter administering the drug-laden bioactive silicon structure to a living animal or human.